High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer

Cancer Research

Volumn 56, Issue 7, 1996, Pages 1654-1659

  Grignon, David J ^a   Sakr, Wael ^a   Toth, Marta ^a   Ravery, Vincent ^a   Angulo, Javier ^a   Shamsa, Falah ^b   Pontes, J Edson ^a   Crissman, John C ^a   Fridman, Rafael ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; GELATINASE; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER SURVIVAL; CLINICAL ARTICLE; CYSTECTOMY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; COLLAGEN; COLLAGENASES; FEMALE; GELATINASES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MICE; MIDDLE AGED; PROTEASE INHIBITORS; PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; URINARY BLADDER NEOPLASMS;

EID: 0029965059     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Woessner, J. F. Matrix metalloproteinases and their inhibitor in connective tissue remodelling. FASEB J., 5: 2145-2154, 1991
2. Matrisian, L. M Metalloproteinases and their inhibitors in tissue remodeling. Trends Genet., 6: 121-125, 1990
3. Liotta, L. A., Steeg, P. A., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64. 327-336, 1991.
4. Monteagudo, C. Merino, M. J., San-Juan, J., Liotta, L. A., and Stetler-Stevenson, W G. Immunohistochemical distribution of collagenase IV in normal, benign and malignant breast tissue Am J. Pathol , 136: 585-592, 1990
5. Davies, B., Miles, D W , Happerfield, L C., Naylor, M. S , Bobrow, L G., Rubens, R. D., and Balkwill, F R Activity of type IV collagenases in benign and malignant breast disease. Br. J. Cancer, 67. 1126-1131, 1993
6. D'Errico, A., Garbisa, S., Liotta, L. A., Castranovo, V., Stetler-Stevenson, W. G., and Grigioni, W. F. Augmentation of collagenase IV, laminin receptor and Ki62 proliferation antigen associated with human colon: gastric and breast carcinoma progression Mod Pathol , 4: 239-246, 1991
7. r 72,000) expression in human prostate: benign and malignant tissue. Cancer Res , 53: 878-883, 1993.
8. Boag, A. H., and Young, I. D Increased expression of the 72 kDa type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization Am. J. Pathol., 144: 585-591, 1994.
9. Davies, B , Waxman, J., Wasan, H , Abel, P , Williams, G., Krausz, T., Neal, D., Thomas, D. Hanby, A., and Balkwill, F. R. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res , 53: 5365-5369, 1993
10. Autio-Harmainen, H., Karttunen, T. Hurskainen, T., Höyhtyä, M., Kauppila, A., and Tryggvason, K. Expression of 72 kDa type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab. Invest., 69: 312-321, 1993
11. Carmichael, D F , Sommer, A., Thompson, R. C. Anderson, D. C., Smith, C G., Welgus, H. G., and Stricklin, G P Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc. Natl. Acad. Sci. USA, 83. 2407-2411, 1986.
12. Goldberg, G. I., Marmer, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S. M., and He, C. Human 72-kilodalton type IV collagenase forms a complex with tissue inhibitor of metalloproteinase designated TIMP-2 Proc. Natl. Acad. Sci. USA, 86. 8207-8211, 1989
13. Stetler-Stevenson, W G , Krutzsch, H. C , and Liotta, L. A. Tissue inhibitor of metalloproteinase (TIMP-2) J Biol Chem., 264: 17374-17378, 1989.
14. DeClerck, Y A , Yean, T-D , Ratzkin, B J , Lu, H. S., and Langley, K. E. Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aoitic endothelial cells. J. Biol Chem., 264: 17445-17453, 1989.
15. Pavloff, N., Staskus, P. W , Kishnani, N. S., and Hawkes, S. P A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem., 267. 17321-17326, 1992.
16. Khokha, R , Waterhouse, P , Yagel, S., Lala, P K , Overall, C. M , Norton, G., and Denhardt, D T. Antisense RNA-induced reduction in murine TIMP level confers oncogenicity on Swiss 3T3 cells. Science (Washington DC), 243 947-950, 1989.
17. Ponton, A., Coulombe, B., and Skup, D Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cell leading to increased levels of collagenolytic activity. Cancer Res , 51: 2138-2143, 1991
18. DeClerck, Y. A , Yean, T. D , Chan, D , Shimada, H., and Langley, K. E. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor Cancer Res , 51: 2151-2157, 1991
19. Albini, A., Melchiori, A , Santi, L , Liotta, L. A., Brown, P. D , and Stetler-Stevenson, W G. Tumor cell invasion inhibited by TIMP-2 J. Natl. Cancer Inst., 83. 775-779, 1991.
20. DeClerck, Y. A., Perez, N., Shimada, H., Boone, T. C., Langley, K. E., and Taylor, S M. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases Cancer Res , 52. 701-708, 1992.
21. Montgomery, A M., Mueller, B. M., Reisfeld, R. A., Taylor, S M., and DeClerck, Y A Effect of tissue inhibitor of metalloproteinase-2 expression on the growth and spontaneous metastasis of a human melanoma cell line Cancer Res., 54: 5467-5473, 1994
22. Lu, X., Levy, M., Weinstein, B I., and Santella, R. M Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer. Cancer Res., 51: 6231-6235, 1991.
23. Zeng, Z-S., Cohen, A. M , Zhang, Z. F., Stetler-Stevenson, W. G., and Guillem, J. G. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin. Cancer Res , 1: 899-906, 1995.
24. Nakano, A , Tani, E., Miyazaki, K , Yamamoto, Y., and Furuyama, J. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J. Neurosurg., 83: 298-307, 1995.
25. Poulsom, R., Hanby, A. M. Pignatelli, M , Jeffrey, R. E., Longcroft, J. M., Rogers, L., and Stamp, G. W. Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas J. Clin. Pathol. (Lond.), 46: 429-436, 1993.
26. Höyhtya, M., Fridman, R., Komarek, D., Porter-Jordan, K., Stetler-Stevenson, W. G., Liotta, L. A , and Liang, C-M. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int J Cancer, 56: 500-505, 1994.
27. Visscher, D W., Hoyhtya, M , Ottosen, S. K., Liang, C-M., Sarkar, F. H., Crissman, J. D., and Fridman, R Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer, 59: 339-344, 1994.
28. Mostofi, F. K , Sobin, H. L., and Torlini, H Histologic Typing of Urinary Bladder Tumors. Geneva, Switzerland: World Health Organization, 1973
29. International Union Against Cancer. TNM Classification of Malignant Tumours, Geneva, Switzerland: Springer-Verlag, 1987.
30. Fridman, R , Toth, M., Peña D., and Mobashery, S. Progelatinase B activation by gelatinase A Cancer Res , 55: 2548-2555, 1995.
31. Skinner, D G. Current perspectives in the management of high grade invasive bladder cancer Cancer (Phila.), 45. 1866-1874, 1980.
32. Lipponen, P. K., Eskelinen, M J , Kiviranta, J., and Pesonen, E. Prognosis of transitional cell bladder cancer a multivariate prognostic score for improved prediction. J Urol , 146: 1535-1540, 1991.
33. Takashi, M., Murase, T., Mizuno, S , Hamajima, N., and Ohno, Y. Multivariate evaluation of prognostic determinants in bladder cancer patients Urol Int., 42: 368-374, 1987.
34. Angulo, J. C., Lopez, J. L., Flores, N , and Toledo, J. D The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification. J. Cancer Res. Clin. Oncol., 119: 578-593, 1993.
35. Kern, W. H. The grade and pathologic stage of bladder cancer. Cancer (Phila.), 53. 1185-1189, 1984
36. Jordan, A. M., Weingarten, J , and Murphy, W M Transitional cell neoplasms of the urinary bladder can biologic potential be predicted from histologic grading? Cancer (Phila.), 60: 2766-2774, 1987.
37. Bell, J. T., Burney, S. W., and Friedell, G. H. Blood vessel invasion in human bladder cancer. J. Urol., 105: 675-678, 1971.
38. Heney, N. M., Proppe, K., Prout, G. R., Jr., Griffin, P. P., and Shipley, W. U. Invasive bladder cancer, tumor configuration, lymphatic invasion and survival. J Urol , 130. 895-897, 1983.
39. Martin, J. E., Jenkins, B. J., Zuk, R. J., Blandy, J. P., and Baithun, S. I. Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J Clin. Pathol. (Lond.), 42: 250-253, 1989.
40. Logothetis, C. J., Dexeus, F. H , Chong, C., Sella, A., Ayala, A G., Ro, J. Y , and Pilat, S. Cisplatin, cyclophosphamide and doxorabicin chemotherapy for unresectable urothelial tumors: the M. D. Anderson experience. J Urol., 141: 33-37, 1989.
41. Sarkis, A. S., Dalbagni, G , Cordon-Cardo, C., Zhang, Z., Sheinfeld, J , Fair, W. R., Herr, H W., and Reuter, V E. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma a marker for disease progression. J. Natl. Cancer Inst., 85: 53-59, 1993.
42. Okada, A., Belloco, J-P., Rouyer, N , Chenard, M-P., Rio, M-C., Chambon, P., and Basset, P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas Proc. Natl. Acad Sci. USA, 92: 2730-2734, 1995.
43. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. and Seiki, M. A matrix metalloproteinase expressed in the surface of tumor cells. Nature (Lond.), 370. 61-65, 1994.
44. Ohtani, H., Tabata, N , and Nagura, H. Immunoelectron microscopic localization of gelatinase A in human gastrointestinal and skin carcinomas: difference between cancer cells and fibroblasts. Jpn J. Cancer Res., 86: 304-309, 1995.
45. Strongin, A. Y., Collier, I., Bannitov, G., Marmer, B. L., Grant, G. A., and Goldberg, G I. Mechanism of cell surface activation of 72 kDa type collagenase: isolation of the activated form of the membrane metalloprotease. J. Biol. Chem., 270 5331-5338, 1995.
46. Nemeth, J. A., and Goolsby, C H. TIMP-2, a growth-stimulatory protein from SV40-transformed human fibroblasts. Exp. Cell Res., 207: 376-382, 1993
47. Hayakawa, T., Yamashita, K., Ohuchi, E., and Shinagawa, A. Cell growth-promoting activity of tissue inhibitor of metalloproteinase-2 (TIMP-2). J Cell Sci., 107 2373-2379, 1994.